|
Clinical_Performance_Status
|
Clinical_Performance_Status |
|
|
Anakinra
|
L04AC03 |
|
|
Rilonacept
|
L04AC04 |
|
|
Ustekinumab
|
L04AC05 |
|
|
Does_the_patient_suffer_from_at_least_one_cardiovascular_disease?
|
Does_the_patient_suffer_from_at_least_one_cardiovascular_disease? |
|
|
Daclizumab
|
L04AC01 |
|
|
Rapid_shallow_breathing_index
|
Rapid_shallow_breathing_index |
|
|
Tumor in remission
|
GECCO_remission |
|
|
Macrocytic_Red_Blood_Cell
|
Macrocytic_Red_Blood_Cell |
|
|
Enterococcus_faecalis
|
Enterococcus_faecalis |
|
|
Inotropic_Support
|
Inotropic_Support |
|
|
macrophage
|
macrophage |
|
|
Obesity
|
Obesity |
|
|
Tildrakizumab
|
L04AC17 |
|
|
Risankizumab
|
L04AC18 |
|
|
Metastatic_Malignant_Neoplasm_in_the_Prostate_Gland
|
Metastatic_Malignant_Neoplasm_in_the_Prostate_Gland |
|
|
Ixekizumab
|
L04AC13 |
|
|
Sarilumab
|
L04AC14 |
|
|
Desoxycorton
|
H02AA03 |
|
|
White_Blood_Cell_Cast_Measurement
|
White_Blood_Cell_Cast_Measurement |
|
